Cowen Starts Acadia Pharmaceuticals (ACAD) at Outperform
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $29.21 +2.67%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 33 | Down: 45 | New: 4
Join SI Premium – FREE
Cowen initiated coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with an Outperform rating and a price target of $46.00.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $27.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'
- Jefferies Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
- Deutsche Bank Starts OHB SE (OHB:GR) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
